专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

91. 发明授权

US07352597B2 Comprehensive power quality controller for substation in power system 失效
标题翻译：电力系统变电站综合电力质量控制器
公开(公告)号：US07352597B2
公开(公告)日：2008-04-01
申请号：US11258557
申请日：2005-10-25
申请人： Zhaoan Wang , Yue Wang , Jun Yang , Xiao Zhang , Wanjun Lei , Weibin Si , Xiaohua Tang , Qiang Dong
发明人： Zhaoan Wang , Yue Wang , Jun Yang , Xiao Zhang , Wanjun Lei , Weibin Si , Xiaohua Tang , Qiang Dong
IPC分类号： H02J3/00
CPC分类号： H02J3/01 , H02J3/1864 , Y02E40/12 , Y02E40/22
摘要： This invention disclosed is a comprehensive power quality controller for substation in the electric power system and includes a Thyristor Controlled Reactor (TCR), pure tuned passive filter Zf, additional inductor L active power filter (APF), and a coupling transformer. The Thyristor Controlled Reactor (TCR) provides inductive reactive power and controls the active power filter (APF) as the current source, it is connected with the additional inductor La in parallel via the coupling transformer, then connected to the passive filter Zf in serial to consist a hybrid power filter system, which is connected to the power grid via the circuit breaker or thyristor. The comprehensive filter system provides required capacitive reactive power and filters the harmonic produced by the load and TCR system itself. Because the capacity of the active power filter (APF) is very small which is less than 1% of the harmonic source capacity, so it is a solution with low cost but simple and reliable control mode. It can suppress influence on the passive filter by the “background harmonic” of the substation and prevent the resonance occurred between the passive filter and power grid impedance.
摘要翻译：本发明公开了一种用于电力系统中变电站的综合功率质量控制器，包括晶闸管控制电抗器（TCR），纯调谐无源滤波器Z附加电感器L有功功率滤波器（APF）和耦合变压器。晶闸管控制电抗器（TCR）提供感应无功功率并控制有源电力滤波器（APF）作为电流源，它通过耦合变压器并联连接到附加电感器L＆amp; 以串联方式连接到无源滤波器Z N以构成混合电力滤波器系统，该系统通过断路器或晶闸管连接到电网。综合滤波系统提供所需的电容无功功率，并对由负载和TCR系统本身产生的谐波进行滤波。由于有源电力滤波器（APF）的容量非常小，小于谐波源容量的1％，因此是一种低成本但简单可靠的控制方式的解决方案。可以通过变电站的“背景谐波”来抑制无源滤波器的影响，防止无源滤波器与电网阻抗之间发生谐振。

92. 发明申请

US20070053846A1 Dry coating and downstream processing of cohesive powders 审中-公开
标题翻译：粘合粉末的干涂层和下游加工
公开(公告)号：US20070053846A1
公开(公告)日：2007-03-08
申请号：US11512453
申请日：2006-08-30
申请人： Rajesh Dave , Robert Pfeffer , Jun Yang , Yuhua Chen
发明人： Rajesh Dave , Robert Pfeffer , Jun Yang , Yuhua Chen
IPC分类号： A61K9/28 , A61K9/14
CPC分类号： C23C24/04 , A61J3/02 , B22F1/0062 , B22F2202/15 , B22F2304/15 , C09D5/033
摘要： The present disclosure is directed to systems and methods for dry particle coating of cohesive powders, and to the dry coated particles/powders produced thereby. The present disclosure is further directed to systems and methods for dry coating of cohesive particles, particularly nanosized particles, to provide enhanced flowability and other advantageous physical and/or functional properties. The disclosed systems and methods offer downstream processing advantages, e.g., for purposes of subsequent fluidization, coating, granulation and/or other particle processing operations, and have applicability in wide ranging industries, including specifically paint-related applications, pharmaceutical applications, food-related applications, cosmetic applications, defense-related applications, electronics-related applications, toner and ink-related applications, and the like.
摘要翻译：本公开涉及用于粘性粉末的干颗粒涂布的系统和方法以及由此产生的干涂层颗粒/粉末。本公开进一步涉及用于干性涂布粘性颗粒，特别是纳米尺寸颗粒以提供增强的流动性和其它有利的物理和/或功能性质的系统和方法。所公开的系统和方法提供下游处理优点，例如用于随后的流化，涂布，造粒和/或其它颗粒加工操作的目的，并且适用于广泛的行业，包括具体的油漆相关应用，药物应用，食品相关应用，化妆品应用，国防相关应用，电子相关应用，调色剂和油墨相关应用等。

93. 发明申请

US20060045249A1 Call authorization and billing message routing capability 有权
标题翻译：呼叫授权和计费消息路由能力
公开(公告)号：US20060045249A1
公开(公告)日：2006-03-02
申请号：US10926503
申请日：2004-08-26
申请人： Xiang Li , Min Liu , John Reid , Guy Starner , Ashish Trivedi , Peng Wang , Yile Wang , Jun Yang , Lei Zhang , Jay Zhao
发明人： Xiang Li , Min Liu , John Reid , Guy Starner , Ashish Trivedi , Peng Wang , Yile Wang , Jun Yang , Lei Zhang , Jay Zhao
IPC分类号： H04M15/00
CPC分类号： H04W12/06 , H04L12/14 , H04L12/1428 , H04L63/08 , H04L63/0892 , H04M15/48 , H04M15/49 , H04M2215/0156 , H04M2215/2026 , H04M2215/204 , H04M2215/32 , H04M2215/46 , H04W4/24 , H04W76/10
摘要： A method and apparatus for routing billing request and response messages to a billing server for serving calls by a particular subscriber. When the subscriber originates a call, an original billing request message is transmitted to an agent server. The agent server determines which billing server serves that subscriber and forwards the billing message to the selected billing server. The billing server responds to the request message with billing request data. Advantageously, this arrangement minimizes the problems of updating a large number of subscriber identification/billing server identification databases.
摘要翻译：一种用于将计费请求和响应消息路由到计费服务器以由特定订户服务呼叫的方法和装置。当用户发起呼叫时，原始计费请求消息被发送到代理服务器。代理服务器确定哪个计费服务器为该订户提供服务，并将该计费消息转发到所选择的计费服务器。计费服务器使用计费请求数据响应请求消息。有利地，这种布置使得更新大量用户识别/计费服务器标识数据库的问题最小化。

94. 发明申请

US20050228075A1 Ordered particle structures and methods of making same 审中-公开
标题翻译：有序粒子结构及其制作方法
公开(公告)号：US20050228075A1
公开(公告)日：2005-10-13
申请号：US10878656
申请日：2004-06-28
申请人： Costas Gogos , Ming-Wan Young , Rajesh Dave , Robert Pfeffer , Theodore Davidson , David Todd , Bainian Qian , Jun Yang
发明人： Costas Gogos , Ming-Wan Young , Rajesh Dave , Robert Pfeffer , Theodore Davidson , David Todd , Bainian Qian , Jun Yang
IPC分类号： C06B21/00 , C06B45/02 , C08J3/20 , C08K7/00 , C10L5/00 , D03D23/00
CPC分类号： C08J3/20 , C06B21/0025 , C06B21/0083 , C06B45/02
摘要： Techniques and methods of formation of ordered mixtures of particles by “clustering”. Clustering comprises local “structuring” consisting of a large “host” and smaller “guest” particles by various techniques. Small amounts of polymer are coated onto solid particles by various means. In one embodiment, an ordered mixture is created wherein the material that is of lesser quantity is of small particle size (the “B” particles) and the “A” particles are of larger size. The “B” particles are then coated onto a single A particle. By creating this ordered structure, each composite particle has the proper or stoichiometric amount of all ingredients. This dry composite material produced is appropriately used in various applications such as pharmaceutical formulations in the form of tablets, capsules, oral suspensions, inhalant, parenteral formulations and the like; energetics manufacture such as but not limited to explosives, propellants and pyrotechnics; agricultural products including but not limited to fertilizers, herbicides and pesticides; nutritional supplements and the like.
摘要翻译：通过“聚类”形成有序粒子混合物的技术和方法。聚类包括通过各种技术由大型“主机”和较小的“客体”粒子组成的本地“结构化”。少量聚合物通过各种方式涂覆在固体颗粒上。在一个实施方案中，产生有序混合物，其中少量的材料具有较小的粒度（“B”颗粒）和“A”颗粒的尺寸较大。然后将“B”颗粒涂覆到单个A颗粒上。通过创建这种有序结构，每个复合颗粒具有适当或化学计量的所有成分。生产的这种干燥复合材料适用于各种应用，例如片剂，胶囊，口服悬浮液，吸入剂，肠胃外制剂等药物制剂; 能源制造，例如但不限于爆炸物，推进剂和烟火; 农产品包括但不限于化肥，除草剂和农药; 营养补品等。

95. 发明申请

US20050148532A1 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types 有权
标题翻译： 14-3-3ζ过表达作为一种不良预后因子，是多种癌症类型的治疗靶点
公开(公告)号：US20050148532A1
公开(公告)日：2005-07-07
申请号：US10938387
申请日：2004-09-10
申请人： Dihua Yu , Jun Yao , Christopher Neal , Wentao Yang , Xiaoyan Zhou , Raphael Pollock , Mien-Chie Hung , Jun Yang , Ping Li , Nina Nguyen
发明人： Dihua Yu , Jun Yao , Christopher Neal , Wentao Yang , Xiaoyan Zhou , Raphael Pollock , Mien-Chie Hung , Jun Yang , Ping Li , Nina Nguyen
IPC分类号： A61K20060101 , A61K48/00 , C12Q1/68 , G01N33/574
CPC分类号： G01N33/574 , C12Q1/6886 , C12Q2600/118 , C12Q2600/136 , C12Q2600/178
摘要： Methods of determining prognosis in a subject with a hyperproliferative disease, including determining expression and/or function of 14-3-3 zeta in the subject, are disclosed. Also disclosed are methods of making a pharmaceutical agent that modulates apoptosis, including the steps of obtaining one or more candidate, testing the one or more candidate substances to determine their ability to modulate the expression and/or function of 14-3-3 zeta, selecting a candidate substance determined to modulate the expression and/or function of 14-3-3 zeta, and making a pharmaceutical composition that includes the selected candidate substance. In addition, methods of treating a subject with a hyperproliferative disease, including making a pharmaceutical agent by the methods set forth herein, and administering the pharmaceutical agent to a subject, are disclosed. The hyperproliferative disease can be cancer, such as breast cancer.
摘要翻译：公开了确定患有过度增生性疾病的受试者的预后的方法，包括确定受试者中14-3-3ζ的表达和/或功能。还公开了制备调节凋亡的药剂的方法，包括获得一种或多种候选物的步骤，测试一种或多种候选物质以确定其调节14-3-3ζ的表达和/或功能的能力，选择确定调节14-3-3ζ的表达和/或功能的候选物质，并制备包含所选候选物质的药物组合物。此外，公开了通过本发明所述的方法制备药剂并且将药剂施用于受试者的治疗患有过度增殖性疾病的受试者的方法。过度增生性疾病可以是癌症，例如乳腺癌。

96. 发明授权

US06379382B1 Stent having cover with drug delivery capability 失效
标题翻译：支架具有药物输送能力
公开(公告)号：US06379382B1
公开(公告)日：2002-04-30
申请号：US09524650
申请日：2000-03-13
申请人： Jun Yang
发明人： Jun Yang
IPC分类号： A61F206
CPC分类号： A61F2/07 , A61F2/90 , A61F2002/072 , A61F2002/075 , A61F2250/0067 , A61L31/10 , A61L31/12 , A61L31/145 , A61L31/16 , A61L2300/00 , A61L31/148 , C08L89/00
摘要： A prosthesis has a cylindrical stent, and a cover provided about the outer periphery of the stent. The cover has at least two layers of materials, with at least one layer of material being permeable to drugs. The layers of material can define at least one chamber therebetween, with a drug loaded into the at least one chamber. Alternatively, the drug can be loaded into the material of one or more layers.
摘要翻译：假体具有圆柱形支架和围绕支架的外周设置的盖。该盖具有至少两层材料，至少一层材料对药物是可渗透的。材料层可以在其间限定至少一个室，其中药物装载到至少一个室中。或者，药物可以装载到一层或多层的材料中。

97. 发明授权

US06362832B1 Method and system for overlaying at least three microarray images to obtain a multicolor composite image 有权
标题翻译：用于覆盖至少三个微阵列图像以获得多色合成图像的方法和系统
公开(公告)号：US06362832B1
公开(公告)日：2002-03-26
申请号：US09388204
申请日：1999-09-01
申请人： Todd J. Stephan , David A. Noblett , Jun Yang
发明人： Todd J. Stephan , David A. Noblett , Jun Yang
IPC分类号： G06T1160
CPC分类号： G01N21/6452 , G01N2021/6421 , G02B21/004 , G02B21/0076 , G02B21/008
摘要： Method and system for overlaying at least three microarray images to obtain a multicolor composite image, which is then displayed on a monitor of a computer system. The microarray images are taken from a microarray scanner of a DNA microarray and can be viewed simultaneously through the use of the image overlays where each image is represented by a different color. Each pixel of the composite image is generated by the OR operator applied to all corresponding pixels of the microarray images. Registration of the microarray images can be altered with a keyboard or mouse of the computer system.
摘要翻译：用于覆盖至少三个微阵列图像以获得多色合成图像的方法和系统，其然后显示在计算机系统的监视器上。微阵列图像从DNA微阵列的微阵列扫描仪获取，并且可以通过使用图像覆盖物同时观察，其中每个图像由不同的颜色表示。合成图像的每个像素由应用于微阵列图像的所有相应像素的OR运算器生成。可以用计算机系统的键盘或鼠标改变微阵列图像的注册。

98. 发明授权

US5989287A Vascular graft assemblies and methods for implanting same 失效
公开(公告)号：US5989287A
公开(公告)日：1999-11-23
申请号：US73743
申请日：1998-05-06
申请人： Jun Yang , George Guo
发明人： Jun Yang , George Guo
IPC分类号： A61B17/11 , A61F2/06 , A61F2/02 , A61F2/04
CPC分类号： A61B17/11 , A61B2017/1107 , A61B2017/1135
摘要： A graft system is provided that includes either a support ring or a support sleeve that is used in providing transitional support to either an end or a side of a graft or a host vessel. The support ring is provided with a generally cylindrical wall and defining a passageway that is adapted for receiving an end of a vein graft or an end of a host vessel. The support ring has a first end and a second end, with the thickness of the wall being greater at the first end than at the second end. The support sleeve is provided with a first side edge, a second side edge, and an opening. The support sleeve surrounds a side opening of a graft or host vessel so that the opening of the support sleeve is aligned with the side opening of the graft or host vessel. The thickness of the support sleeve is greater at the opening than at the first and second side edges.

99. 发明授权

US5935168A Glutaraldehyde-fixed bioprostheses 失效
标题翻译：戊二醛固定生物假体
公开(公告)号：US5935168A
公开(公告)日：1999-08-10
申请号：US044667
申请日：1998-03-20
申请人： Jun Yang , Shih-Hwa Shen
发明人： Jun Yang , Shih-Hwa Shen
IPC分类号： A61L27/00 , A61L27/36 , A61F2/02
CPC分类号： A61L27/3687 , A61L27/3604 , A61L2400/02 , Y10S623/916 , Y10S623/918 , Y10S623/92 , Y10S623/921
摘要： Methods for treating glutaraldehyde-fixed collagenous tissues to mitigate there propensity for subsequent calcification and to improve durability. Collagenous tissues which have been harvested and cross-linked by glutaraldehyde are exposed to a carboxyl activating agent to convert the free carboxyl (COOH) groups of the collagen molecules to activated carboxyl moieties (e.g., o-acylisourea). Thereafter, the collagenous tissue is exposed to a compound capable of reacting with the activated carboxyl moieties (e.g., o-acylisourea) to form non-carboxyl side groups. Monofunctional and multifunctional amines are examples of compounds which may be utilized to react with the activated carboxyl moieties to form such non-carboxyl side groups. Thereafter, the collagenous tissue is again exposed to glutaraldehyde. If the non-carboxyl side groups have functional amino groups (NH.sub.2), such additional exposure to glutaraldehyde will result in additional glutaraldehyde cross-linking of the collagen molecules and resultant improvement of durability.
摘要翻译：用于治疗戊二醛固定的胶原组织以减轻随后钙化倾向并改善耐久性的方法。已经通过戊二醛收获和交联的胶原组织暴露于羧基活化剂，以将胶原分子的游离羧基（COOH）基团转化成活化的羧基部分（例如邻酰基异脲）。此后，将胶原组织暴露于能够与活化的羧基部分反应的化合物（例如，O-酰基异脲）以形成非羧基侧基。单官能和多官能胺是可用于与活化的羧基部分反应以形成非羧基侧基的化合物的实例。此后，胶原组织再次暴露于戊二醛。如果非羧基侧基具有官能氨基（NH 2），则另外暴露于戊二醛将导致胶原分子的另外的戊二醛交联，从而提高耐久性。

100. 发明授权

US5891196A Method for actively binding heparin to crosslinked biological tissues 失效
标题翻译：肝素与交联生物组织积极结合的方法
公开(公告)号：US5891196A
公开(公告)日：1999-04-06
申请号：US843504
申请日：1997-04-16
申请人： Catherine Ting Lee , Jun Yang
发明人： Catherine Ting Lee , Jun Yang
IPC分类号： A61L33/10 , A61L33/00 , A61L17/00
CPC分类号： A61L33/0029 , A61L33/0011 , Y10S514/822
摘要： Methods for binding heparin to biological or synthetic materials which are to be implanted within a mammalian body. In instances where connective tissue proteins or other components of the material having adequate carboxyl groups present thereon, the method comprises a) contacting the material with a carboxyl-activating agent, b) contacting the material with a polyamine compound to form amide-bound polyarnine side chains at the sites of the previously activated carboxyl groups, and c) contacting the material with heparin such that heparin will become bound to the amino groups on the polyamine side chains. In other applications wherein the connective tissue proteins or other molecular entities of the material are devoid of or deficient in carboxyl groups, the method will comprise a) contacting the material with a carboxyl-activating agent in combination with a polyamine compound which has functional carboxyl groups thereon such that at least some of the functional carboxyl groups of the polyamine compound will become activated and will react with some of the amino groups on the polyamine compounds to form a polyamine network interlocked within the molecular structure of the material, and b) contacting the material with heparin such that heparin will become bound to amino groups on the polyamine network.
摘要翻译：将肝素结合到植入哺乳动物体内的生物或合成材料的方法。在结缔组织蛋白质或具有足够羧基的物质的其它成分存在于其上的情况下，该方法包括：a）使材料与羧基活化剂接触，b）使该材料与多胺化合物接触以形成酰胺键结的聚胺一侧链在先前活化的羧基的位点，和c）使该材料与肝素接触，使得肝素将结合到多胺侧链上的氨基。在其中所述材料的结缔组织蛋白质或其它分子实体缺乏或缺乏羧基的其它应用中，所述方法将包括：a）使所述材料与羧基活化剂与具有官能羧基的多胺化合物组合使得多胺化合物的至少一些官能羧基将被活化并将与多胺化合物上的一些氨基发生反应以形成在该材料的分子结构内互锁的多胺网络，以及b）使材料与肝素，使肝素将结合到多胺网络上的氨基。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式